MedTrace Logo

Uptake of an Omega-3 Oil in Healthy Adults

NCT05650294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-03-02

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the uptake of two different omega-3 fatty acid preparations in healthy adults. The main question it aims to answer is whether the two different preparations have the same uptake after single dose supplementation.

Conditions

  • Absorption
  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

PL+ omega 3 fatty acids

PL+ omega 3 fatty acids is a food supplement that combines krill oil and FO EE. The dose will be around 1250 mg EPA+DHA.

DIETARY_SUPPLEMENT

FO EE fatty acids

A conventional fish oil food supplement containing EPA and DHA in the EE form. The dose will be 1250 mg EPA+DHA.

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Aker BioMarine Human Ingredients AS

    lead INDUSTRY

Principal Investigators

  • Daniel Menzel · BioTeSys GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2023-02-17
Completion
2023-02-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05650294 on ClinicalTrials.gov